retatrutide clinical trial updates FDA Approval Status: July 2026 Update Retatrutide: What It Is &

The glucagon-like peptide-1 receptor (GLP-1R) regulates insulin secretion, carbohydrate metabolism and appetite, and is an important target for treatment of type II diabetes and obesity

If you lost access to semaglutide or tirzepatide, you have options.

Find out about the symptoms, causes, and treatments here.

PMCID: PMC9709280

The increasingly popular obesity and diabetes drugs known as glucagon-like peptide-1 receptor agonists do not seem to worsen suicidality despite previous concerns, according to recent data published in BMJ.Case reports that linked GLP-1s to suicidality have raised regulatory concerns and left many wondering if these medications are harming the patients they intend to help, Laurent Azoulay, PhD, a

Louisiana Ozempic Mounjaro Lawyer: Laborde Earles puts 350 years of personal injury power in your corner